Raymond James Financial’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Raymond James Financial's IART Position: Q3 2026 in Review
Raymond James Financial increased its Integra LifeSciences (IART) stake by 19% in Q3 2026, buying an estimated $902K and bringing the position to 326,731 shares worth $5.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2680.
Raymond James Financial first reported a position in IART in Q4 2024 and has held it in 8 quarters since. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Raymond James Financial held 326,731 shares of Integra LifeSciences worth $5.32M as of Q3 2026.
- Raymond James Financial bought 52,270 Integra LifeSciences shares in Q3 2026, an estimated $902K.
- Integra LifeSciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2680 holding.
- Raymond James Financial first reported a position in Integra LifeSciences in Q4 2024 and has held it in 8 quarters since.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.